Robust genome and RNA editing via CRISPR nucleases in PiggyBac systems
CRISPR/Cas-mediated genome editing in human pluripotent stem cells (hPSCs) offers unprecedented opportunities for developing in vitro disease modeling, drug screening and cell-based therapies. To efficiently deliver the CRISPR components, here we developed two all-in-one vectors containing Cas9/gRNA...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
KeAi Communications Co., Ltd.
2022-08-01
|
| シリーズ: | Bioactive Materials |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2452199X22000615 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|